Overview
Dermot Gleeson practices in Sheffield, United Kingdom. Mr. Gleeson is rated as an Elite expert by MediFind in the treatment of Autoimmune Hepatitis. His top areas of expertise are Autoimmune Hepatitis, Hepatitis, Alcoholic Cirrhosis, and Hepatitis A.
His clinical research consists of co-authoring 42 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles in the study of Autoimmune Hepatitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Autoimmune HepatitisMr. Gleeson isElite. Learn about Autoimmune Hepatitis.
- Distinguished
- HepatitisMr. Gleeson isDistinguished. Learn about Hepatitis.
- Advanced
- Alcoholic CirrhosisMr. Gleeson isAdvanced. Learn about Alcoholic Cirrhosis.
- Hepatitis AMr. Gleeson isAdvanced. Learn about Hepatitis A.
- Experienced
- Cerebellar DegenerationMr. Gleeson isExperienced. Learn about Cerebellar Degeneration.
- CholangitisMr. Gleeson isExperienced. Learn about Cholangitis.
- CirrhosisMr. Gleeson isExperienced. Learn about Cirrhosis.
- JaundiceMr. Gleeson isExperienced. Learn about Jaundice.
- Muir-Torre SyndromeMr. Gleeson isExperienced. Learn about Muir-Torre Syndrome.
- Non-Alcoholic Fatty Liver DiseaseMr. Gleeson isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.